-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
DMK PHARMACEUTICALS Corp quarterly/annual Depreciation history and growth rate from 2010 to 2022.
- DMK PHARMACEUTICALS Corp Depreciation for the quarter ending September 30, 2023 was $67K, a 83.2% decline year-over-year.
- DMK PHARMACEUTICALS Corp Depreciation for the twelve months ending September 30, 2023 was $636K, a 56.9% decline year-over-year.
- DMK PHARMACEUTICALS Corp annual Depreciation for 2022 was $1.48M, a 3.34% increase from 2021.
- DMK PHARMACEUTICALS Corp annual Depreciation for 2021 was $1.44M, a 9.79% increase from 2020.
- DMK PHARMACEUTICALS Corp annual Depreciation for 2020 was $1.31M, a 119% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)